0000899243-22-038102.txt : 20221209
0000899243-22-038102.hdr.sgml : 20221209
20221209165338
ACCESSION NUMBER: 0000899243-22-038102
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221207
FILED AS OF DATE: 20221209
DATE AS OF CHANGE: 20221209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cardama Alfonso Quintas
CENTRAL INDEX KEY: 0001760104
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38811
FILM NUMBER: 221455409
MAIL ADDRESS:
STREET 1: C/O TCR2 THERAPEUTICS INC.
STREET 2: 100 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TCR2 THERAPEUTICS INC.
CENTRAL INDEX KEY: 0001750019
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 474152751
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-949-5200
MAIL ADDRESS:
STREET 1: 100 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-12-07
0
0001750019
TCR2 THERAPEUTICS INC.
TCRR
0001760104
Cardama Alfonso Quintas
C/O TCR2 THERAPEUTICS
100 BINNEY STREET
CAMBRIDGE
MA
02142
0
1
0
0
Chief Medical Officer
Common Stock
131200
D
Common Stock
2022-12-07
4
S
0
3928
1.283
D
127272
D
Common Stock
2022-12-08
4
S
0
4014
1.256
D
123258
D
The sales reported represent the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and intended to qualify under Rule 10b5-1.
/s/ Margaret Siegel as Attorney-in-Fact
2022-12-09